KZIA Kazia Therapeutics Ltd ADR

USD 3.44 +0.35 ( +11.33%)
Icon

Kazia Therapeutics Ltd ADR (KZIA) Financial Statements

COMMON STOCK | Biotechnology | NSD
stockTargetAdvisor

Strong Buy

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

USD 3.44

+0.35 (+11.33%)

USD 4.30M

0.05M

USD 3.00(-12.79%)

N/A

Icon

KZIA

Kazia Therapeutics Ltd ADR (USD)
COMMON STOCK | NSD
USD 3.44
+0.35 ( +11.33%)

Kazia Therapeutics Ltd ADR (KZIA) Annual Income Statement (USD)

KZIA Quarterly Financials (USD)

Frequently Asked Questions About Kazia Therapeutics Ltd ADR (KZIA) Stock

Kazia Therapeutics Ltd ADR's (KZIA) last reported annual revenue was USD 2.31 Million.

Kazia Therapeutics Ltd ADR's (KZIA) annual revenue growth rate based on the revenue reported in the past 5 years is : 330.27%

Kazia Therapeutics Ltd ADR's(KZIA) is not profitable as of its last reported annual financials.

The net profit margin for Kazia Therapeutics Ltd ADR's(KZIA) from its laster reported year is -1160.23%

The return on equity (ROE) for Kazia Therapeutics Ltd ADR's(KZIA) from its last reported annual financials is : -2634.33%

The return on assets (ROA) for Kazia Therapeutics Ltd ADR's(KZIA) from its last reported annual financials is : -71.63%

The return on invested capital (ROIC) for Kazia Therapeutics Ltd ADR's(KZIA) from its last reported annual financials is : -1270.77%

The Debt to Equity ratio for Kazia Therapeutics Ltd ADR's(KZIA) from its last reported annual financials is : 0.00%

The dividend yield for Kazia Therapeutics Ltd ADR's(KZIA) from its laster reported year is 0.00%

Kazia Therapeutics Ltd ADR's(KZIA) has negative cash flow as of its last reported annual financials.

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

Icon
What to like

Icon
What not to like

Loading...